China Digest: Worg secures close to $58m; Vathin, HanchorBio raise funds; KKR invests in pet hospital chain

China Digest: Worg secures close to $58m; Vathin, HanchorBio raise funds; KKR invests in pet hospital chain

Photo by National Cancer Institute on Unsplash

Biopharmaceutical firm Worg snapped up almost $58 million in a Series B round while medical device maker Vathin and Taiwanese biotech firm HanchorBio also received funding. Separately, KKR has invested in pet hospital chain Ruichen. 

Biopharmaceutical firm Worg bags almost $58m

Clinical stage biopharmaceutical firm Worg has received 400 million yuan ($57.5 million) in a Series B round participated by five local institutional investors, including Junson Capital,  Kaitai Capital and Puhua Capital.  

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter